Trial Profile
A drug interaction and pharmacokinetics study of idelalisib and GS-563117 in white males.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Idelalisib (Primary)
- Indications Haematological malignancies
- Focus Pharmacokinetics
- 11 Dec 2015 New trial record